| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $113.10B | $105.86B | $102.77B |
| YoY Revenue Growth % | +6.8% | +3.0% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $36.00B | $31.83B | $31.04B |
| Operating Margin % | 31.8% | 30.1% | 30.2% |
| Net Income (GAAP) | $30.51B | $26.97B | $26.30B |
| EBITDA (Normalized) | $40.07B | $35.64B | $34.74B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $12.61B | -$8.80B | $44.98B |
| Capital Expenditures (CapEx) | $5.09B | $4.76B | $4.62B |
| Free Cash Flow (FCF) | $7.52B | -$13.57B | $40.36B |
| FCF Margin % | 6.7% | -12.8% | 39.3% |
| Return on Invested Capital (ROIC %) | 2.1% | 2.0% | 20.6% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $1.40T | $1.34T | $46.02B |
| Total Stockholders' Equity | $303.24B | $293.96B | $94.41B |